Monday, February 09, 2026 | 03:56 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Page 2 - Syngene

Top stock recommendations by Anand Rathi: Buy Asian Paints, Cummins

Trading ideas by Jay Anand Thakkar, CMT -Assistant Vice President - Equity Research, Anand Rathi Shares and Stock Brokers

Top stock recommendations by Anand Rathi: Buy Asian Paints, Cummins
Updated On : 15 Oct 2019 | 8:01 AM IST

Syngene to develop nutrition products for Herbalife

Syngene, the contract research and manufacturing unit of Biocon is looking to expand its business to work on products for customers that target Indian consumers. It has signed up HerbalLife Nutrition, a nutrition company to develop nutrition based products that can be sold by the company in the country. This is the first nutrition research and development Lab in India by HerbalLife. The new facility is located in Syngene campus and has a separate Good Manufacturing Practices (GMP) formulation lab to support product testing, sampling and end-product development. The lab currently has 10 members combined from Syngene and HerbalLife. "Apart from bringing the global portfolio of products to India, we also endeavour to develop flavors that appeal to the Indian palate. Setting up the Nutrition R&D Lab in collaboration with Syngene will give us the ability to turnaround new products faster, and introduce them to the market quicker. This is the fifth dedicated centre and second for ...

Syngene to develop nutrition products for Herbalife
Updated On : 03 Mar 2017 | 12:18 AM IST

Massive fire in Biocon's Syngene complex in Bengaluru, no casualties

The Karnataka Fire Department tweeted that it has sent over eight fire tenders to quell the blaze

Massive fire in Biocon's Syngene complex in Bengaluru, no casualties
Updated On : 13 Dec 2016 | 8:46 AM IST

Syngene Q1 net up 28% at Rs 60 crore

Shares of the company closed at Rs 427.75 on BSE

Syngene Q1 net up 28% at Rs 60 crore
Updated On : 21 Jul 2016 | 8:16 PM IST

Syngene Q4 net up 18% to Rs 66.5 cr on higher business from customers

This, because business from contract research and manufacturing services from global pharma firms increased

Syngene Q4 net up 18% to Rs 66.5 cr on higher business from customers
Updated On : 26 Apr 2016 | 9:29 PM IST